OTCPK:EKTA.Y

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. More Details


Snowflake Analysis

Adequate balance sheet with questionable track record.


Similar Companies

Share Price & News

How has Elekta's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: EKTA.Y's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-3.6%

EKTA.Y

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

-6.3%

EKTA.Y

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: EKTA.Y underperformed the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: EKTA.Y underperformed the US Market which returned 13.8% over the past year.


Shareholder returns

EKTA.YIndustryMarket
7 Day-3.6%-1.7%-0.8%
30 Day1.6%-3.5%-5.7%
90 Day32.5%12.2%8.6%
1 Year-5.2%-6.3%17.5%16.5%16.4%13.8%
3 Year21.1%17.7%70.0%65.6%36.9%27.8%
5 Year90.2%83.3%139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is Elekta's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Elekta undervalued compared to its fair value and its price relative to the market?

37.13x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: EKTA.Y ($12.3) is trading above our estimate of fair value ($8.66)

Significantly Below Fair Value: EKTA.Y is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: EKTA.Y is good value based on its PE Ratio (37.1x) compared to the US Medical Equipment industry average (49.1x).

PE vs Market: EKTA.Y is poor value based on its PE Ratio (37.1x) compared to the US market (17.6x).


Price to Earnings Growth Ratio

PEG Ratio: EKTA.Y is poor value based on its PEG Ratio (2.7x)


Price to Book Ratio

PB vs Industry: EKTA.Y is overvalued based on its PB Ratio (5.5x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is Elekta forecast to perform in the next 1 to 3 years based on estimates from 14 analysts?

13.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EKTA.Y's forecast earnings growth (13.8% per year) is above the savings rate (2.2%).

Earnings vs Market: EKTA.Y's earnings (13.8% per year) are forecast to grow slower than the US market (22.9% per year).

High Growth Earnings: EKTA.Y's earnings are forecast to grow, but not significantly.

Revenue vs Market: EKTA.Y's revenue (7% per year) is forecast to grow slower than the US market (9.9% per year).

High Growth Revenue: EKTA.Y's revenue (7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: EKTA.Y's Return on Equity is forecast to be low in 3 years time (17.6%).


Next Steps

Past Performance

How has Elekta performed over the past 5 years?

30.9%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EKTA.Y has high quality earnings.

Growing Profit Margin: EKTA.Y's current net profit margins (8%) are lower than last year (8.4%).


Past Earnings Growth Analysis

Earnings Trend: EKTA.Y's earnings have grown significantly by 30.9% per year over the past 5 years.

Accelerating Growth: EKTA.Y's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: EKTA.Y had negative earnings growth (-2.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (1.8%).


Return on Equity

High ROE: EKTA.Y's Return on Equity (14.7%) is considered low.


Next Steps

Financial Health

How is Elekta's financial position?


Financial Position Analysis

Short Term Liabilities: EKTA.Y's short term assets (SEK14.6B) exceed its short term liabilities (SEK10.2B).

Long Term Liabilities: EKTA.Y's short term assets (SEK14.6B) exceed its long term liabilities (SEK8.7B).


Debt to Equity History and Analysis

Debt Level: EKTA.Y's debt to equity ratio (100.2%) is considered high.

Reducing Debt: EKTA.Y's debt to equity ratio has increased from 89.6% to 100.2% over the past 5 years.

Debt Coverage: EKTA.Y's debt is well covered by operating cash flow (23.6%).

Interest Coverage: EKTA.Y's interest payments on its debt are well covered by EBIT (12.6x coverage).


Balance Sheet


Next Steps

Dividend

What is Elekta current dividend yield, its reliability and sustainability?

0.80%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: EKTA.Y's dividend (0.8%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.72%).

High Dividend: EKTA.Y's dividend (0.8%) is low compared to the top 25% of dividend payers in the US market (4.94%).


Stability and Growth of Payments

Stable Dividend: EKTA.Y is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: EKTA.Y is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: EKTA.Y is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EKTA.Y's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.7yrs

Average management tenure


CEO

Gustaf Salford (43 yo)

0.25

Tenure

Mr. Gustaf Salford serves as Acting President and Chief Executive Officer at Elekta AB (publ) since June 2, 2020. He served as Chief Financial Officer and Executive Vice President of Elekta AB (publ) since ...


Leadership Team

NamePositionTenureCompensationOwnership
Laurent Leksell
Founder & Chairman7yrskr1.40m2.11%
SEK 98.8m
Gustaf Salford
Acting President & CEO0.25yrno data0.0019%
SEK 87.2k
Johan Adeback
Group Treasurer & Acting CFO0.25yrno data0.0010%
SEK 49.2k
Cecilia Ketels
Head of Investor Relations1.33yrsno datano data
Jonas Bolander
General Counsel3.83yrsno data0.000050%
SEK 2.3k
Mattias Thorsson
Head of Corporate Communications & Public Affairsno datano datano data
Ioannis Panagiotelis
Executive VP of APAC3.08yrsno datano data
Karin Nyberg
Executive Vice President of Human Resources3.67yrsno data0.00031%
SEK 14.5k
James Hoey
Head of External Relations5.17yrsno datano data
John Lapré
President of Brachy Solutions8.25yrsno data0.00046%
SEK 21.6k
Maurits Wolleswinkel
President of Linac solutions6.08yrsno data0.0042%
SEK 198.8k
Anming Gong
Executive VP & Head of Region Chinano datano datano data

3.7yrs

Average Tenure

55yo

Average Age

Experienced Management: EKTA.Y's management team is considered experienced (3.7 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Laurent Leksell
Founder & Chairman7yrskr1.40m2.11%
SEK 98.8m
Jan Secher
Independent Director10.67yrskr700.00k0.0075%
SEK 353.5k
Wolfgang Reim
Independent Director9.67yrskr630.00k0.0046%
SEK 214.7k
Johan Malmquist
Independent Director5.67yrskr700.00k0.0052%
SEK 245.2k
Birgitta Göransson
Independent Director15.67yrskr790.00k0.0016%
SEK 75.0k
Caroline Cooke
Director3.08yrskr780.00k0.048%
SEK 2.2m
Cecilia Wikström
Independent Director2.08yrskr630.00k0.00029%
SEK 13.6k

7.0yrs

Average Tenure

63yo

Average Age

Experienced Board: EKTA.Y's board of directors are considered experienced (7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Elekta AB (publ)'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Elekta AB (publ)
  • Ticker: EKTA.Y
  • Exchange: OTCPK
  • Founded: 1972
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: kr42.812b
  • Listing Market Cap: kr4.688b
  • Shares outstanding: 382.08m
  • Website: https://www.elekta.com

Number of Employees


Location

  • Elekta AB (publ)
  • Kungstensgatan 18
  • Box 7593
  • Stockholm
  • Stockholm County
  • 103 93
  • Sweden

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
EKTA.FOTCPK (Pink Sheets LLC)YesSeries B Registered SharesUSUSDMar 1994
EKTA BOM (OMX Nordic Exchange Stockholm)YesSeries B Registered SharesSESEKMar 1994
EJXBDB (Deutsche Boerse AG)YesSeries B Registered SharesDEEURMar 1994
0O5HLSE (London Stock Exchange)YesSeries B Registered SharesGBSEKMar 1994
EKTABSBATS-CHIXE (BATS 'Chi-X Europe')YesSeries B Registered SharesGBSEKMar 1994
EKTA.YOTCPK (Pink Sheets LLC)UNSPONSOD ADRUSUSDDec 2008

Biography

Elekta AB (publ), a medical technology company, provides clinical solutions for cancer and brain disorders worldwide. The company offers radiotherapy treatment systems, such as Versa HD, a dose delivery ac ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/28 04:34
End of Day Share Price2020/09/25 00:00
Earnings2020/07/31
Annual Earnings2020/04/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.